Most importantly, a number of drugs used for treatment of diverse asthma, sepsis, liver injury, insulin resistance, postmenopausal osteoporosis, Parkinson’s disease, diabetic nephropathy and cancers exert their effects through modulation of non-coding RNAs/SIRT1 axis. This evidence concerns the gene SIRT1 and Insulin resistance.